Prophylaxis for endophthalmitis following intravitreal injection: Antisepsis and antibiotics

American Journal of Ophthalmology

Volumn 152, Issue 5, 2011, Pages

  Wykoff, Charles C ^a   Flynn Jr , Harry W ^a   Rosenfeld, Philip J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; MOXIFLOXACIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTISEPSIS; BACTERIAL COUNT; CATARACT EXTRACTION; DRUG COST; DRUG EFFICACY; ENDOPHTHALMITIS; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 80054994268     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.07.002     Document Type: Editorial

References (18)

1. C.A. McCannel Meta-analysis of endophthalmitis following intravitreal injection of anti-VEGF agents: causative organisms and possible prevention strategies Retina 31 4 2011 654 661
2. A.A. Moshfeghi, P.J. Rosenfeld, and H.W. Flynn Jr Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 4 2011 662 668
3. L.P. Aiello, A.J. Brucker, and S. Chang Evolving guidelines for intravitreous injections Retina 24 5 Suppl 2004 S3 S19 (Pubitemid 39391785)
4. R.L. Berkelman, B.W. Holland, and R.L. Anderson Increased bactericidal activity of dilute preparations of povidone-iodine solutions J Clin Microbiol 15 4 1982 635 639 (Pubitemid 12135619)
5. M.G. Speaker, and J.A. Menikoff Prophylaxis of endophthalmitis with topical povidone-iodine Ophthalmology 98 12 1991 1769 1775
6. H. Shimada, S. Arai, and H. Nakashizuka Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine Am J Ophthalmol 151 1 2011 11 17 e1
7. C.C. Wykoff, H.W. Flynn Jr, and D.P. Han Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use Am J Ophthalmol 151 1 2011 4 6
8. M.M. Whitacre, and R.S. Crockett Tolerance of intravitreal povidone-iodine in rabbit eyes Curr Eye Res 9 8 1990 725 732 (Pubitemid 20312995)
9. R.O. Darouiche, M.J. Wall Jr, and K.M. Itani Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis N Engl J Med 362 1 2010 18 26
10. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 8 2009 1498 1501
11. O. Halachmi-Eyal, Y. Lang, Y. Keness, and D. Miron Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac J Cataract Refract Surg 35 12 2009 2109 2114
12. J.Y. Hyon, I. Eser, and T.P. O'Brien Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus J Cataract Refract Surg 35 9 2009 1609 1613
13. P. Costello, S.J. Bakri, and P.M. Beer Vitreous penetration of topical moxifloxacin and gatifloxacin in humans Retina 26 2 2006 191 195 (Pubitemid 44400716)
14. J.M. Moss, S.R. Sanislo, and C.N. Ta Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections Ophthalmology 117 11 2010 2141 2145
15. R.E. Fintelmann, E.N. Hoskins, and T.M. Lietman Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Arch Ophthalmol 129 4 2011 399 402
16. D. Miller, P.M. Flynn, and I.U. Scott In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 4 2006 479 483
17. S.J. Kim, and H.S. Toma Ophthalmic antibiotics and antimicrobial resistance, a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 7 2011 1358 1363
18. A.R. Bhavsar, J.M. Googe Jr, and C.R. Stockdale Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 12 2009 1581 1583